SII launches India’s first indigenous pneumococcal vaccine


Serum Institute of India, Pune has launched India’s first indigenously developed pneumococcal vaccine – PNEUMOSIL. The cost-efficient vaccine was launched in the presence of Dr. Harsh Vardhan, Minister of Health and Family Welfare on Monday.

PNEUMOSIL has been developed through a collaboration spanning over a decade among Serum Institute of India Pvt Ltd, PATH and Bill and Melinda Gates Foundation. This significant milestone is aimed at improving pneumococcal conjugate vaccine affordability and enabling sustainable access for low-and middle-income countries, read a press statement quoted by a ANI report.

The vaccine will provide effective and long-lasting protection for children against pneumococcal diseases. PNEUMOSIL® is relatively cost-efficient at high-volumes and more accessible over the long term for the countries that need it most.

Speaking about the launch, Dr. Harsh Vardhan, Union Minister, Ministry of Health & Family Welfare was quoted as saying by the report, “It is a great moment of pride to witness Serum Institute take forward the ‘Make in India’ legacy, with the launch of India’s first indigenously developed Pneumococcal Conjugate Vaccine. It is a significant milestone for the country’s public health care which will ensure that children are protected better against Pneumococcal disease with an affordable and high-quality vaccine.”

“I am sure, Serum Institute of India will continue their endeavour to develop many more life-saving vaccines in the future also on the lines of the clarion call of our Hon’ble Prime Minister “VOCAL FOR LOCAL” and fulfill our Hon’ble Prime Minister’s dream ‘ATMA NIRBHAR BHARAT’,” he further stated.


Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video